IAS will occur from April 5–7, 2019 at the Marriott Chicago Downtown Magnificent Mile in Chicago, Illinois.
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. After successful completion of the evaluation form online, participants may immediately print their documentation of credit.
For questions regarding this educational activity, please call 609-371-1137.
After attending IAS, participants should be able to:
- Describe the relationship between the pathophysiology of immune-mediated chronic inflammatory diseases and the mechanism of action of new and existing treatments
- Outline the roles of current and emerging immunosuppressive, anti-inflammatory, and disease-modifying treatments for immune-mediated chronic inflammatory diseases in treatment paradigms
- Develop collaborative care guidance that improves the management of patients with multiple manifestations of immune-mediated disease
This activity is designed for dermatologists, gastroenterologists, immunologists, rheumatologists, nurse practitioners, nurses, physician assistants, and other healthcare professionals involved in the management of patients with immune-mediated inflammatory diseases.
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 15.25 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for 15.25 contact hours.
These activities are approved for 15.25 contact hours (1.525 CEU) of continuing pharmacy education (UAN JA0006201-0000-19-004-L01-P).
Each of these educational activities is a knowledge-based activity.
A Virtual Reality Tour: New Goals of Therapy for Psoriatic and Rheumatoid Arthritis: Managing Comorbidities, Preserving Joints, and Pursuing Remission With Biologics
This activity has been planned and implemented by North American Center for Continuing Medical Education, LLC (NACCME) and Med Learning Group. NACCME is jointly accredited by the Accreditation Council for Continu¬ing Medical Education (ACCME), the Ac¬creditation Council for Pharmacy Educa¬tion (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 1.0 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hours.
These activities are approved for 1.0 contact hours (0.01 CEU) of continuing pharmacy education (UAN JA0006201-9999-19-018-L01-P).
This educational activity is a knowledge-based activity.
ACPE Credit Policy
The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system.
Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. The reporting function into CPE Monitor will only be available for 60 days after your completion of the activity. Under ACPE Policy, NACCME will not be able to report your credit to CPE Monitor after this 60-day period.
Innovation Theaters (non-accredited)
These are promotional programs and no CE credits are offered. All attendees, please be advised that information—e.g., your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.
Educational Grant Supporters
NACCME would like to thank the following companies who have supported IAS through educational grants: Celgene Corporation, Genentech, GlaxoSmithKline, Janssen Biotech, Inc., and Lilly
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved.
Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.
Note: Information contained herein is subject to change without notice.